Kaisa Health Group Holdings Limited (HKG:0876)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1260
+0.0090 (7.69%)
At close: Mar 27, 2026

HKG:0876 Income Statement

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
139.11185.36185.88191.5209.63
Revenue Growth (YoY)
-24.95%-0.28%-2.93%-8.65%14.04%
Cost of Revenue
88.47103.5104.81108.93112.21
Gross Profit
50.6481.8681.0782.5797.42
Selling, General & Admin
86.2793.59107.4132.54157.3
Research & Development
16.9112.4816.84--
Other Operating Expenses
---17.4317.22
Operating Expenses
106.04105.08124.82154.8175.34
Operating Income
-55.4-23.23-43.74-72.24-77.93
Interest Expense
-0.59-0.78-3.67-7.73-8.18
Interest & Investment Income
1.032.513.234.141.32
Currency Exchange Gain (Loss)
-0.990.350.110.78-1.81
Other Non Operating Income (Expenses)
-1.37-20.070.6-13.044.81
EBT Excluding Unusual Items
-57.31-41.21-43.48-88.08-81.79
Gain (Loss) on Sale of Investments
10.56-9.77-21.3-12.0766.02
Gain (Loss) on Sale of Assets
-0.810.1968.96-0.01-2.21
Asset Writedown
----73.36-
Other Unusual Items
0.622.111.862.5629.19
Pretax Income
-46.95-48.686.05-170.9611.2
Income Tax Expense
-0.11.92-0.11.1723.53
Earnings From Continuing Operations
-46.85-50.66.15-172.13-12.32
Net Income to Company
-46.85-50.66.15-172.13-12.32
Minority Interest in Earnings
0.174.251.3248.8114.68
Net Income
-46.68-46.367.47-123.322.36
Net Income to Common
-46.68-46.367.47-123.322.36
Shares Outstanding (Basic)
5,0425,0425,0425,0425,042
Shares Outstanding (Diluted)
5,0425,0425,0425,0425,042
EPS (Basic)
-0.01-0.010.00-0.020.00
EPS (Diluted)
-0.01-0.010.00-0.020.00
Free Cash Flow
--39.05-46.7-71.96-136.6
Free Cash Flow Per Share
--0.01-0.01-0.01-0.03
Gross Margin
36.41%44.16%43.61%43.11%46.47%
Operating Margin
-39.82%-12.53%-23.53%-37.72%-37.17%
Profit Margin
-33.55%-25.01%4.02%-64.40%1.13%
Free Cash Flow Margin
--21.07%-25.12%-37.58%-65.16%
EBITDA
-47.73-15.56-33.22-50.07-60.68
EBITDA Margin
-34.31%-8.39%-17.87%-26.15%-28.95%
D&A For EBITDA
7.677.6710.5222.1717.25
EBIT
-55.4-23.23-43.74-72.24-77.93
EBIT Margin
-39.82%-12.53%-23.53%-37.72%-37.17%
Effective Tax Rate
----210.00%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.